Name | Pemigatinib |
---|---|
Synonyms |
Pemigatinib
3-(2,6-Difluoro-3,5-dimethoxyphenyl)-1-ethyl-8-(4-morpholinylmethyl)-1,3,4,7-tetrahydro-2H-pyrrolo[3',2':5,6]pyrido[4,3-d]pyrimidin-2-one 2H-Pyrrolo[3',2':5,6]pyrido[4,3-d]pyrimidin-2-one, 3-(2,6-difluoro-3,5-dimethoxyphenyl)-1-ethyl-1,3,4,7-tetrahydro-8-(4-morpholinylmethyl)- |
Description | Pemigatinib is a selective FGFR inhibitor in development for the treatment of patients with cholangiocarcinoma. |
---|---|
Related Catalog | |
Target |
Target: FGFR[1] |
References |
Density | 1.4±0.1 g/cm3 |
---|---|
Molecular Formula | C24H27F2N5O4 |
Molecular Weight | 487.499 |
Exact Mass | 487.203125 |
LogP | 0.66 |
Index of Refraction | 1.620 |
Storage condition | 2-8℃ |